1. 258818-34-7
2. 258818-34-7 (free Base)
3. At-2347
4. 2-[[(2s)-1-[(2s)-5-amino-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic Acid
5. Glycylglycyl-l-valyl-l-leucyl-l-valyl-l-glutaminyl-l-prolylglycine
6. Larazotide [usan:inn]
7. Unii-zn3r5560zv
8. Larazotide-acetate
9. At 2347
10. Larazotide (usan/inn)
11. Zn3r5560zv
12. Chembl2105646
13. Dtxsid30180526
14. Chebi:177799
15. Zinc68009799
16. Db05645
17. H-gly-gly-val-leu-val-gln-pro-gly-oh
18. Hy-106268
19. Cs-0025478
20. D09351
21. 818l347
22. Q27295752
Molecular Weight | 725.8 g/mol |
---|---|
Molecular Formula | C32H55N9O10 |
XLogP3 | -3.6 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 21 |
Exact Mass | 725.40718899 g/mol |
Monoisotopic Mass | 725.40718899 g/mol |
Topological Polar Surface Area | 301 Ų |
Heavy Atom Count | 51 |
Formal Charge | 0 |
Complexity | 1290 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in autoimmune diseases, diabetes mellitus type 1, and gastrointestinal diseases and disorders (miscellaneous).
AT-1001 is an orally administered octapeptide zonulin receptor antagonist that appears to exert its inhibitory effect on gliadin-induced tight junction disassembly by blocking putative zonulin receptors on the luminal surface of the small intestine.
LOOKING FOR A SUPPLIER?